Marco Investment Management Llc
Source: SEC Form 13F · as of Mar 2026Marco Investment Management Llc holds 16 biotech & pharma companies tracked by BioSniper, totaling $105.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$105.7M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 139,533 | $30.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 76,378 | $20.7M |
| AMGNAMGEN INC | 43,519 | $15.3M |
| MRKMerck & Co., Inc. | 95,705 | $11.5M |
| JNJJOHNSON & JOHNSON | 28,716 | $7.0M |
| ABTABBOTT LABORATORIES | 64,549 | $6.6M |
| PFEPFIZER INC | 134,125 | $3.8M |
| GILDGILEAD SCIENCES, INC. | 19,101 | $2.7M |
| NVSNovartis AG | 13,875 | $2.1M |
| BMYBRISTOL MYERS SQUIBB CO | 34,278 | $2.1M |
| LLYELI LILLY & Co | 1,979 | $1.8M |
| PMPhilip Morris International Inc | 3,825 | $632K |
| MCKMcKesson Corporation | 673 | $582K |
| NVONovo Nordisk A/S | 6,550 | $241K |
| MMSIMerit Medical Systems Inc. | 3,140 | $216K |
| ELDNEledon Pharmaceuticals, Inc. | 30,344 | $93K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.